Status:
ACTIVE_NOT_RECRUITING
Communication Skills Intervention to Promote Transition Into Survivorship
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
M.D. Anderson Cancer Center
Maimonides Medical Center
Conditions:
Hodgkin's Lymphoma
Diffuse Large B-cell Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to improve the communication skills of physicians who transition lymphoma cancer patients from the end of treatment to survivorship.
Eligibility Criteria
Inclusion
- Physicians:
- who treat patients with DLBCL and HD as per self report
- Patients of Physicians:
- have a new diagnosis of Hodgkin's or Diffuse Large B-cell Lymphoma as per pathology report or physician assessment in medical record and/or clinical judgment of the treating physician treated with curative intent.
- For part 1 - have scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.
- For part 2 (longitudinal phase): - have new scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.
- be at least 18 years old
- speak English well enough, in the judgment of the consenting professional, to be able to understand all aspects of the study, provide informed consent, and be able to complete all study measures.
Exclusion
- Physicians:
- who do not have adequate patients in their clinical practice to meet the 8 patient enrollment requirement for patients with either DLBCL or HD as per self report
- Patients of Physicians:
- show evidence of cognitive impairment severe enough to preclude giving permission to the study staff, or completing the survey instruments of the study.
- as per physician judgment, patient's prognosis and/or co-morbidities make them inappropriate for participation in a survivorship study.
- For Part 2 ONLY (longitudinal phase):
- those who consented to part 1, consult recording, of the study.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2026
Estimated Enrollment :
314 Patients enrolled
Trial Details
Trial ID
NCT01483664
Start Date
November 1 2011
End Date
November 1 2026
Last Update
December 18 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampa General Hospital
Tampa, Florida, United States, 33606
2
Moffitt Cancer Center
Tampa, Florida, United States, 33612
3
Memorial Sloan Kettering at Basking Ridge
Basking Ridge, New Jersey, United States, 07920
4
Maimonides Medical Center
Brooklyn, New York, United States, 11220